This is MediShield, an enthusiastic team of experienced
specialists and young biomedical engineers devoted to integrate
new innovative ideas into the medical field. MediShield's primary
focus is to reduce costs and improve safety during surgery with intuitive
new tools and innovative work-flow concepts. The companies projects
are supported by STW, several industrial partners, two medical
centra and the Delft University of Technology.
We state that innovation is the process that translates
knowledge into economic growth and social well-being. As the demand
for health care is on the rise, so is the desire for effective
innovative medical solutions.
MediShield BV has announced to start the clinical
validation of the MSIS trocar system for laparoscopy, the
most performed type of Minimally Invasive Surgery worldwide.
The principal of this new ''isolator system'' can
be applied on different fields in minimally invasive surgery. However, the
first isolator systems are developed for standard laparoscopic
instruments. The basis of those Isolator systems is a special trocar
(MSIS trocar). Different from all other trocar systems, the MSIS
trocar does not only guide instruments through the skin and tissue
layers. Moreover, the MSIS trocar creates a small "cleanroom" around the
surgical site that protects the instruments and incision against
potentially contaminating surfaces and air. Furthermore, in
case of contagious diseases as Hepatitis or HIV, the MSIS trocar System
protects the surgeon, staff and operation room against tissue, fluid or
particles coming from the patient. This innovative surical trocar was
designed in collaboration with surgeons and Biomedical engineers, keeping
patient safety in mind.
Posted by T.Horeman on
November 31, 2011 Read
more
Medishield